Cerity Partners’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $884K | Buy |
48,572
+869
| +2% | +$15.8K | ﹤0.01% | 1575 |
|
|
2025
Q1 | $946K | Buy |
47,703
+4,575
| +11% | +$90.8K | ﹤0.01% | 1443 |
|
|
2024
Q4 | $762K | Sell |
43,128
-7,750
| -15% | -$137K | ﹤0.01% | 1544 |
|
|
2024
Q3 | $1.02M | Buy |
50,878
+30,637
| +151% | +$612K | ﹤0.01% | 1388 |
|
|
2024
Q2 | $226K | Buy |
20,241
+2,783
| +16% | +$31.1K | ﹤0.01% | 1966 |
|
|
2024
Q1 | $115K | Buy |
17,458
+7,458
| +75% | +$49.2K | ﹤0.01% | 2191 |
|
|
2023
Q4 | $45.2K | Sell |
10,000
-300
| -3% | -$1.36K | ﹤0.01% | 1812 |
|
|
2023
Q3 | $36.9K | Buy |
10,300
+300
| +3% | +$1.07K | ﹤0.01% | 1364 |
|
|
2023
Q2 | $36.9K | Buy |
+10,000
| New | +$36.9K | ﹤0.01% | 1586 |
|